Skip to main content

Table 2.

Correlation between KRAS/BRAF mutations and phosphorylated extracellular‐regulated kinase (p‐ERK1/2) expression in endometrial cancer

p‐ERK1/2 expression n KRAS sequence BRAF sequence
Exon 1 Exon 11 Exon 15
Mutation Wild type Mutation Wild type Mutation Wild type
None 13  3 10 0 13 0 13
Weak 13  4  9 0 13 0 13
Moderate 12  1 11 0 12 0 12
Strong  6  2  4 0  6 0  6
Total 44 10 34 0 44 0 44